Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials
EPA but not EPA/DHA is associated with reductions in coronary plaque burden when given as adjunct to statins in patients with coronary artery disease.
Authors
- Deepak L. Bhatt (ORCID: https://orcid.org/0000-0002-1278-6245)
- John P. Sheppard (ORCID: https://orcid.org/0000-0002-8040-8481)
- Suraj Dahal (ORCID: https://orcid.org/0000-0003-3737-8376)
- Leonard Palatnic
- John Nelson (ORCID: https://orcid.org/0000-0003-2455-0296)
- Matthew Jay Budoff (ORCID: https://orcid.org/0000-0002-9616-1946)
- Suvasini Lakshmanan (ORCID: https://orcid.org/0009-0005-2147-4576)
- Sion Roy
Institutions
- Cedars-Sinai Medical Center (US)
- University of California, Los Angeles (US)
- Virginia Commonwealth University (US)
- UCLA Medical Center (US)
- University of Iowa Hospitals and Clinics (US)
- University of California System (US)
- Cardiovascular Institute Hospital (JP)
- Cedars-Sinai Smidt Heart Institute (US)
- Harbor–UCLA Medical Center (US)
- University at Buffalo, State University of New York (US)
- Virginia Commonwealth University Medical Center (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Acta cardiologica. Supplementum
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1080/00015385.2025.2538404
- Citations
- 1
- Primary Topic
- Fatty Acid Research and Health
- Type
- article
- Field-Weighted Citation Impact
- 1.12